HIMALAYA Overall Survival Prominence and Other Routes to the Peak-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HIMALAYA Overall Survival Prominence and Other Routes to the Peak

Published:2024-01-11 Issue: Volume: Page:
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Abou-Alfa Ghassan K.¹²³,Sangro Bruno⁴

Affiliation:

1. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

2. Weill Medical College, Cornell University, New York, New York

3. Trinity College Dublin, Dublin, Ireland

4. Liver Unit and HPB Oncology Area, Clínica Universidad de Navarra and CIBEREHD, Pamplona, Spain

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2813832/jamaoncology_aboualfa_2024_le_230037_1704314730.87322.pdf

Reference5 articles.

1. Critical appraisal of guideline recommendations on systemic therapies for advanced hepatocellular carcinoma: a review.;Cappuyns;JAMA Oncol,2023

2. The use of (network) meta-analysis in clinical oncology.;Ter Veer;Front Oncol,2019

3. Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: results of the AB-Real study.;Fulgenzi;Eur J Cancer,2022

4. SO-15 Four-year overall survival update from the phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.;Sangro;Ann Oncol,2023

5. European Society for Medical Oncology. ESMO-MCBS scorecards: tremelimumab. Accessed December 4, 2023. https://www.esmo.org/guidelines/esmo-mcbs/esmo-mcbs-for-solid-tumours/esmo-mcbs-scorecards/scorecard-358-1

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP